SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Amarin Corporation PLC Announces Publication of Additional Inflammatory Marker Data From MARINE and ANCHOR Phase 3 Clinical Trials in the American Journal of Cardiovascular Drugs